The California Institute for Quantitative Biosciences (QB3) has renewed and expanded a three-year agreement with Pfizer Inc. to collaborate on research projects at the University of California with the potential to transform world-class science into better medicine.
More than one million people are diagnosed and treated each year in the United States for lumbar spinal stenosis (LSS), a condition that occurs from the narrowing of the spinal canal. Peter Staats, M.D., in conjunction with Riverview Medical Center, is offering LSS patients a groundbreaking new procedure, mild® (minimally invasive spinal decompression) that safely and therapeutically reduces pain and improves mobility.
The British Editorial Society of Bone & Joint Surgery announce the launch of Bone & Joint360, (www.bj360.boneandjoint.org.uk) – a new bi-monthly digest for the global orthopaedic community.
The National Association For Continence (NAFC) announced the Most Innovative New Product award in the 2011-2012 issue of DISCOVERIES®, a directory of the newest products and services for people living in the US with bladder and bowel control problems.
The book’s promise is that you can use self-hypnosis to overcome the psychological roadblocks that are keeping you from attaining optimal health, weight and happiness.
If you could find out if you had an increased risk of heart attack or stroke, wouldn’t you want to know? Even if you are fit and healthy, coronary artery disease (CAD) or peripheral artery disease (PAD) are conditions with little to no symptoms and can put you at an increased risk of heart attack or stroke.
Kids and parents alike need more time to “be kids.”
New iPhone and iPad application (The ICN Food List) provides urology patients with a comprehensive database of foods and beverages to help reduce painful symptom flares. Developed for interstitial cystitis patients, it is ideal for use when shopping or eating out. Clinicians, nursing staff and dietitians can use it as an educational tool as well.
American Association of Critical-Care Nurses and Elsevier | MC Strategies launch online nursing course -- AACN: Critical Care Pharmacology -- to help bedside clinicians further develop competencies in the safe administration of medications used in critical care settings.
A new device help people with foot drop walk.
Last week a U.S. company announced initial Phase I/II clinical trial results for ALS (Amyotrophic Lateral Sclerosis).
Clorox Professional Products Company, a division of The Clorox Company announced today the introduction of Clorox Healthcare™ Hydrogen Peroxide Cleaner Disinfectant Wipes and Spray, a new line of ready-to-use, one-step cleaner disinfectants engineered with a patented activated hydrogen peroxide (H2O2) formula. These activated hydrogen peroxide products are registered by the U.S. Environmental Protection Agency (EPA) to kill 32 bacteria and viruses in 30-seconds to one minute, the fastest non-bleach contact time available.
Ablitech’s lead product rounds up pancreatic and bladder cancer cells in laboratory tests and prevents further growth.
Novo Nordisk (NYSE:NVO) announced today that the company will establish a type 1 diabetes research and development center in Seattle, Wash., U.S. The new center will combine Novo Nordisk's history of innovation and leadership in diabetes treatment with the company's growing expertise in immunotherapy.
Columbia University grants Health Fidelity exclusive rights to robust portfolio of patents, software code, and trademarks for commercialization of MedLEE, clinical NLP technology to improve usability of health information and support data-driven healthcare.
MedLion, Inc., a pioneering Direct Primary Care practice, today announced the company’s expansion into the Fresno region by including William Work, M.D., in its fast-growing network of affiliated physicians. MedLion’s direct primary care practice provides patients access to high quality and affordable personalized primary care without the high cost and burdens associated with traditional health insurance.
According to Dian Griesel, Ph.D, a nutritionist, it’s misguided to think of eating healthy as a “resolution.” Like most of our resolutions, this one will soon be broken.
GeneKey Corp. announced today that it has launched a personalized cancer service that empowers patients and their oncology team to develop treatment strategies based on insight into the biology of individual tumors.
The Vanderbilt Center for Neuroscience Drug Discovery announced today that new drug candidates for schizophrenia generated from its ongoing collaboration with Janssen Pharmaceutica, NV, are now entering the stage of preparation for first-in-human clinical testing.
“This is a major step forward in the evaluation of this approach as a potential treatment for major psychiatric diseases. It could lead to a fundamental advance in the treatment of schizophrenia,” said P. Jeffrey Conn, Ph.D., co-director of the Vanderbilt Center for Neuroscience Drug Discovery
CareConscious, a North Carolina-based start-up company, has completed a license agreement with the University of Wisconsin-Milwaukee Research Foundation to bring care management tools to family caregivers across the country.
The Rockefeller University Press (RUP) has unveiled new iPhone and iPad apps for its three journals: The Journal of Cell Biology (JCB), The Journal of Experimental Medicine (JEM), and The Journal of General Physiology (JGP). iPhone, iPad, and iPod touch users can read full-text articles anywhere at any time, even without an Internet connection.
As the healthcare industry migrates to accountable care and medical home models, NoMoreClipboard (NMC), the leading personal health record provider, announced a collaborative agreement with iMPak Health, L.L.C. to develop IT solutions that combine easy-to-use electronic home healthcare journals and various health screening devices with clinical portals and personal health records. These end-to-end electronic solutions will securely and wirelessly transmit health information from a patient’s home to their health care providers and caregivers.
Four clinical sites in the U.S. have completed required training and are certified to provide novel therapy to patients using the NovoTTF-100A System™; three additional clinical sites planned by year end.
Allstate New Jersey Insurance Company raised a record-breaking $50,000 this year for its Quotes for a Cure program to benefit The Cancer Institute of New Jersey. Over the past three years in its efforts to lend a hand in the fight against cancer, Allstate New Jersey has raised a total of $95,000 through the campaign. The funding supports research, treatment, and prevention and education programs at New Jersey’s only NCI-Comprehensive Cancer Center.
The new Techna Institute at University Health Network (UHN) has signed its first agreement with INO of Quebec City and Hamilton.
Own Brain Helps Singles Make Better Choices - A scientific test, now called BrainDesire, helps singles make better choices by tapping into their own brain for finding Mr Right or Ms Right.
USDA does not support public health interests, says Solo GI Nutrition CEO Saul Katz
DARA's DB959 Phase 1b clinical study for the treatment of type 2 diabetes - results demonstrated that DB959 is safe and well-tolerated and show support for pharmacological activity.
As we enter the holiday season, not only do the number of alcohol related accidents increase but also, so do waistlines. Most people experience their (relatively) lowest weight and best muscle tone around September every year.
Endoscope manufacturer Optim LLC announces the asset acquisition of Precision Endoscopic Technologies (formerly MAX Endoscopy of Mentor, OH). The new company, Precision Endoscopic Technologies LLC will operate as a division of Optim LLC and will be co-located at Optim’s headquarters, 64 Technology Park Road, Sturbridge, MA.
Arnold Palmer Hospital for Children is the first hospital in the United States to receive innovative new x-ray imaging technology that decreases radiation exposure to young patients and produces high-quality images.
An 11-month-old partnership between UCSF and Pfizer, Inc., aimed at rapidly moving new therapies into human clinical trials, has selected its first projects for funding and joint development.
Sauce products fly from shelves as product developers, professional chefs and home cooks use them to create regional and ethnic recipes that cater to various dietary needs.
The University of Arkansas for Medical Sciences (UAMS) announces the start of a Phase 1 clinical trial to study the safety of a novel vaccine to prevent the recurrence of breast cancer. UAMS has three research subjects enrolled in the Phase 1 clinical trial and plans on completing the trial sometime in 2012 after studying the safety of the vaccine in up to 18 research subjects. After the safety testing phase is completed, UAMS expects to conduct another clinical trial using the vaccine on up to 50 research subjects.
A new line of sleepwear now available to breast cancer survivors is the result of an ongoing research partnership between Ryerson University and Princess Margaret Hospital that examines how the side effects of surgery and treatment affect women’s physical comfort, confidence and sexuality.
Last fall Bayshore Community Hospital became the sixth hospital in Meridian’s Monmouth and Ocean county system. With a strong focus on customer service, alignment with Meridian Health clinical best practices, a new leadership team, and countless new physicians, Bayshore has begun to develop an exciting plan to create a destination hospital that will become the pride of the community.
Cedars-Sinai has combined efforts with the Translational Genomics Research Institute (TGen) in Arizona so researchers may offer joint clinical trials and collaborate to develop personalized therapies that could lead to more effective cancer treatments.
The Johns Hopkins University (JHU) has entered into a drug-discovery research collaboration with Eisai, a pharmaceutical company based in Tokyo, to develop proprietary small-molecule drugs for a range of brain conditions such as schizophrenia, pain, brain tumors and Alzheimer’s disease.
Jersey Shore University Medical Center announces the completion of its first procedure with Abiomed’s Impella® 2.5 heart pump. Jersey Shore is the first and only regional hospital to include the World’s Smallest Heart Pump in their portfolio of treatment options to assist critically ill heart patients.
Simple steps, like daily home blood pressure monitoring, may help manage risk factors for diabetes.
Thanks to funding from the National Institutes of Health, Nationwide Children’s Hospital will test the ability of a drug commonly used to improve immune function in pediatric cancer patients to help prevent hospital-acquired infection after severe trauma. It will be the first clinical trial aimed at improving immune function in critically injured children.
Cardium Therapeutics (CXM) has received FDA 510(k) clearance to market and sell Excellagen™ professional-use advanced wound care product for diabetic foot ulcers, pressure ulcers and other dermal wounds.
The George Washington University School of Public Health and Health Services, the RCHN Community Health Foundation (RCHN CHF), and Rho have partnered with The Merck Childhood Asthma Network, Inc. (MCAN) to implement a $4 million collaborative initiative titled the Community Healthcare for Asthma Management and Prevention of Symptoms (CHAMPS). The initial program will focus on five non-profit, federally qualified community health centers (CHCs) located in: Tucson, AZ; Grand Rapids, MI area; and Rincon, PR.
The American Nurses Credentialing Center (ANCC) and Lippincott Williams & Wilkins (LWW), part of Wolters Kluwer Health, today announced a joint marketing agreement between the Magnet Recognition Program® and The Journal of Nursing Administration (JONA). Beginning with the October 2011 issue, JONA will become “The Official Leadership Journal of the Magnet Recognition Program.”
The American Society of Anesthesiologists (ASA) announced the release of an iPad app, the first journal app of its kind in the anesthesiology specialty. Anesthesiology for the iPad, developed and distributed by the ASA’s publishing partner, Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, provides full mobile accessibility for all member and individual subscribers of Anesthesiology, the top-ranked journal in anesthesiology.
The CordStat® EtOH assay screens umbilical cord tissue for the direct alcohol biomarker phosphatidylethanol (PEth), an abnormal phospholipid formed in cell tissues following alcohol ingestion.
The American Association of Clinical Endocrinologists (AACE) and Takeda Pharmaceuticals North America Inc. (Takeda) have partnered to launch the Diabetes Navigator (http://DiabetesNavigator.AACE.com), a compendium capturing a selection of useful and reliable type 2 diabetes information available online for patients and caregivers.
The return of a delectable signature item to Panera Bread® bakery-café locations during October will help New Jersey’s only NCI-designated Comprehensive Cancer Center tackle a disease that affects one in eight U.S. women -- breast cancer. In its tenth year of marking National Breast Cancer Awareness Month, participating Panera locations will offer their Pink Ribbon Bagel. Proceeds from the local sale of this unique treat will benefit The Cancer Institute of New Jersey.
The Methodist Hospital has been chosen as a study site for a new type of stent graft device that is designed for the repair of certain types of aortic aneurysms near or involving the blood vessels that lead to the kidneys. The Ventana Fenestrated Stent Graft System is made by Endologix Inc., which is sponsoring both the feasibility and pivotal studies of the device.
Hospital for Special Surgery announced the establishment of HSS Spine & Sport in Jupiter, Florida. This first HSS expansion beyond the New York region is a direct response to patient and physician demand.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right